Physician

Abbas Raza, D.O

According to 2025 Medicare claims, Abbas Raza, D.O (NPI: 1710391958) practices nephrology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08103-3101.

Raza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 354 traditional Medicare patients, billed 1,181 HCPCS/CPT codes, and received $115,703 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). 2023 Part D data shows 169 prescription claims across 50 beneficiaries totaling $24,541 in drug costs. 2020 DME data shows 12 claims. Open Payments data shows 4 records totaling $86. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $29,499 and ending at $24,541. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$104K$209K2019 Medicare payment: $115,717 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $208,765 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $205,251 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $159,457 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $123,331 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $115,703 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20194451,287$115,717
20207292,136$208,765
20217112,103$205,251
20226601,897$159,457
20233991,357$123,331
20243541,181$115,703

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $29,499 (USD; Tot_Drug_Cst)2016 Drug cost: $38,584 (USD; Tot_Drug_Cst)2017 Drug cost: $38,218 (USD; Tot_Drug_Cst)2018 Drug cost: $11,707 (USD; Tot_Drug_Cst)2019 Drug cost: $32,675 (USD; Tot_Drug_Cst)2020 Drug cost: $19,616 (USD; Tot_Drug_Cst)2021 Drug cost: $46,298 (USD; Tot_Drug_Cst)2022 Drug cost: $36,457 (USD; Tot_Drug_Cst)2023 Drug cost: $24,541 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201565486$29,499
2016109715$38,584
201797631$38,218
201876308$11,707
201980301$32,675
202068218$19,616
202184398$46,298
202279457$36,457
202350169$24,541
2024N/RN/RN/R

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$144$2872019 Medicare payment: $226 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $287 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R13$226
2020N/R12$287
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99291Critical care, first 30-74 minutes2932$188
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes173183$153
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes133426$105
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes208431$70
90935Hemodialysis procedure with physician evaluation6593$60

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$86Otsuka America Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abbas Raza, D.O?

Tedicare shows public-source Medicare data for Abbas Raza, D.O (NPI 1710391958), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abbas Raza, D.O have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abbas Raza, D.O?

Abbas Raza, D.O is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Abbas Raza, D.O have Open Payments data?

Abbas Raza, D.O has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.